Von Hippel–Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype–Phenotype Features
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Von Hippel–Lindau disease-associated endolymphatic sac tumors (VHL-associated ELSTs) present diagnostic challenges due to their rarity and nonspecific symptoms. This study describes clinical, pathological and genotypic features to guide treatment. We retrospectively analyzed seven patients with VHL-associated ELSTs. The mean age of otologic symptom [hearing loss (100%) and facial nerve paralysis (85.71%)] onset was 22.43 ± 8.68 years (range: 10–33). Surgical management included trans-labyrinthine and subtotal temporal bone resection approaches. Among three patients with severe preoperative facial nerve dysfunction, two underwent great auricular nerve grafting improved to House–Brackmann grade IV, while one receiving hypoglossal–facial nerve anastomosis reached grade V. Genetic testing identified pathogenic VHL gene missense mutations in three patients. Two female patients demonstrated disease progression during pregnancy. Literature analysis revealed exon-specific patterns: Exon 1 mutations correlated with cerebellar/spinal hemangioblastomas in female patients, while Exon 3 mutations were associated with multisystem tumors. These findings support that VHL-associated ELSTs manifest early with otologic symptoms and demonstrate exon-specific phenotypic patterns. Optimal management requires complete surgical resection, genetic diagnosis, and a multidisciplinary approach to address these complex tumors and achieve favorable outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865
Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition
Li, C., Fu, C., Zhou, W., Li, H., Liu, Z., Wu, G., He, T., Shen, M., & Liu, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02366-x · Cited by 60 · cited 1×
“The VHL protein serves as the substrate-recognition subunit of the VBC-CUL2 E3 ubiquitin ligase complex, targeting hypoxia-inducible factors (HIFs) for proteasomal degradation [4].”
Rajakumar, A., Michael, H. M., Daftary, A., Jeyabalan, A., Gilmour, C., & Conrad, K. P. (2008) · Placenta · doi:10.1016/j.placenta.2007.11.015 · Cited by 48 · cited 1×
“While VHL-related HIF abnormalities raise theoretical preeclampsia concerns, enhanced prenatal surveillance is unsupported [45].”
Research works printed but not linked: 42
- Melmon, 1964, Lindau’s Disease. Review of the Literature and Study of a Large Kindred, Am. J. Med., 36, 595, 10.1016/0002-9343(64)90107-X · doi:10.1016/0002-9343(64)90107-x
- Talukdar, 2022, Endolymphatic sac tumor: Single-institution series of seven cases with updated review of literature, Eur. Arch. Otorhinolaryngol., 279, 2591, 10.1007/s00405-021-07047-2 · doi:10.1007/s00405-021-07047-2
- Zanoletti, 2017, Endolymphatic sac tumour in von Hippel-Lindau disease: Management strategies, Acta Otorhinolaryngol. Ital., 37, 423, 10.14639/0392-100X-1402 · doi:10.14639/0392-100x-1402
- Chittiboina, 2015, Von Hippel-Lindau Disease, Handb. Clin. Neurol., 132, 139, 10.1016/B978-0-444-62702-5.00010-X · DOI · Paper page
- Manski, 1997, Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease, JAMA, 277, 1461, 10.1001/jama.1997.03540420057030 · DOI · Paper page
- Chadha, 2021, The world report on hearing, 2021, Bull. World Health Organ., 99, 242, 10.2471/BLT.21.285643 · DOI · Paper page
- Wu, 2023, Surgical management of endolymphatic sac tumor: Classification, outcomes and strategy. A single institution’s experience, Eur. Arch. Otorhinolaryngol., 280, 69, 10.1007/s00405-022-07447-y · doi:10.1007/s00405-022-07447-y
- Buckley, 2024, Saturation genome editing maps the functional spectrum of pathogenic VHL alleles, Nat. Genet., 56, 1446, 10.1038/s41588-024-01800-z · DOI · Paper page
- Skalova, 2008, Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): Report of two cases with analysis of the VHL gene, Pathol. Res. Pract., 204, 599, 10.1016/j.prp.2008.01.016 · DOI
- Rao, 2010, Endolymphatic sac tumor with von Hippel-Lindau disease: Report of a case with analysis of von Hippel-Lindau gene and review, Ann. Diagn. Pathol., 14, 361, 10.1016/j.anndiagpath.2009.10.001 · doi:10.1016/j.anndiagpath.2009.10.001
- Yang, 2014, Endolymphatic sac tumor with von Hippel-Lindau disease: Report of a case with atypical pathology of endolymphatic sac tumor, Int. J. Clin. Exp. Pathol., 7, 2609
- 2002, Endolymphatic sac tumor and von Hippel-Lindau disease. Review of the literature, Acta Otorrinolaringol. Esp., 53, 515, 10.1016/S0001-6519(02)78344-1 · doi:10.1016/s0001-6519(02)78344-1
- Lodi, M., Marrazzo, A., Cacchione, A., Macchiaiolo, M., Romanzo, A., Mastronardi, L., Diomedi-Camassei, F., Carboni, A., Carai, A., and Gandolfo, C. (2021). Synchronous Presentation of Rare Brain Tumors in Von Hippel-Lindau Syndrome. Diagnostics, 11. · doi:10.3390/diagnostics11061005
- Jensen, 2004, Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: The role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression, J. Neurosurg., 100, 488, 10.3171/jns.2004.100.3.0488 · DOI
- Codreanu, 2010, Isolate vertigo crisis revealing an endolymphatic sac tumor, Rom. J. Morphol. Embryol., 51, 387
- Priesemann, 2006, Benefits of screening in von Hippel-Lindau disease--comparison of morbidity associated with initial tumours in affected parents and children, Horm. Res., 66, 1
- Kawahara, 1999, VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease, Neurology, 53, 208, 10.1212/WNL.53.1.208 · doi:10.1212/wnl.53.1.208
- Tsoli, 2025, New Developments in VHL-Associated Neuroendocrine Neoplasms, Curr. Oncol. Rep., 27, 59, 10.1007/s11912-024-01631-5 · DOI
- Butman, 2007, Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease, JAMA, 298, 41, 10.1001/jama.298.1.41 · DOI
- Schweizer, 2021, Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumours, Neuropathol. Appl. Neurobiol., 47, 756, 10.1111/nan.12741 · DOI
- Bausch, 2016, Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry, Head. Neck., 38, E673, 10.1002/hed.24067 · doi:10.1002/hed.24067
- Kim, 2013, Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: Findings, results, and indications, Laryngoscope, 123, 477, 10.1002/lary.23646 · DOI
- Gioacchini, 2022, Symptoms and clinical features in patients affected by endolymphatic sac tumor: A systematic review and meta-analysis, Eur. Arch. Otorhinolaryngol., 279, 5081, 10.1007/s00405-022-07469-6 · doi:10.1007/s00405-022-07469-6
- Su, 2013, Endolymphatic sac tumor with von Hippel-Lindau disease: Report of two cases with testing of von Hippel-Lindau gene, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 48, 913
- Crunkhorn, 2021, Vestibular Function in Children with Von Hippel-Lindau Disease, J. Int. Adv. Otol., 17, 361, 10.5152/iao.2021.0190 · doi:10.5152/iao.2021.0190
- Tan, 2024, Endolymphatic Sac Tumors Associated with von Hippel-Lindau: A Case Report Highlighting Opportunity for Novel Orphan Drug Therapy, Otol. Neurotol., 45, e644, 10.1097/MAO.0000000000004307 · DOI
- Bambakidis, 2004, Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status, Otol. Neurotol., 25, 773, 10.1097/00129492-200409000-00021 · doi:10.1097/00129492-200409000-00021
- Schipper, 2006, Endolymphatic sac tumours: Surgical management, J. Otolaryngol., 35, 387, 10.2310/7070.2006.0082 · doi:10.2310/7070.2006.0082
- Friedman, 2013, Surgical management of endolymphatic sac tumors, J. Neurol. Surg. B Skull Base, 74, 12
- Sinclair, 2018, Gamma knife radiosurgery in the management of endolymphatic sac tumors, Surg. Neurol. Int., 9, 18, 10.4103/sni.sni_312_17 · doi:10.4103/sni.sni_312_17
- Simone, 2011, Infratentorial craniospinal irradiation for von Hippel-Lindau: A retrospective study supporting a new treatment for patients with CNS hemangioblastomas, Neuro Oncol., 13, 1030, 10.1093/neuonc/nor085 · doi:10.1093/neuonc/nor085
- Lonser, 2014, Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease, J. Neurosurg., 120, 1055, 10.3171/2014.1.JNS131431 · DOI · Paper page
- Mao, 2021, Expression of VHL, VEGF and HIF-1α in endolymphatic sac tumors, Zhonghua Bing Li Xue Za Zhi, 50, 1228
- Xu, 2024, VHL missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response, J. Immunother. Cancer, 12, e009963, 10.1136/jitc-2024-009963 · DOI
- Binderup, 2013, Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition, Dan. Med. J., 60, B4763
- Binderup, 2017, Survival and causes of death in patients with von Hippel-Lindau disease, J. Med. Genet., 54, 11, 10.1136/jmedgenet-2016-104058 · DOI · Paper page
- Wang, 2018, Risk factors for survival in patients with von Hippel-Lindau disease, J. Med. Genet., 55, 322, 10.1136/jmedgenet-2017-104995 · doi:10.1136/jmedgenet-2017-104995
- Ye, 2012, Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease, J. Neurosurg., 117, 818, 10.3171/2012.7.JNS12367 · doi:10.3171/2012.7.jns12367
- Binderup, 2015, New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy, Neurology, 85, 1500, 10.1212/WNL.0000000000002064 · doi:10.1212/wnl.0000000000002064
- Frantzen, 2012, Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease, Neurology, 79, 793, 10.1212/WNL.0b013e3182661f3c · doi:10.1212/wnl.0b013e3182661f3c
- Farage, 2018, Pregnancy-induced growth of a spinal hemangioblastoma: Presumed mechanisms and their implications for therapeutic approaches, Int. J. Womens Health, 10, 325, 10.2147/IJWH.S166216 · doi:10.2147/ijwh.s166216
- Laviv, 2019, Accelerated growth of hemangioblastoma in pregnancy: The role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway, Neurosurg. Rev., 42, 209, 10.1007/s10143-017-0910-4 · DOI
Metadata
- Authors
- Wang, Q., Huang, J., Zhao, Z., Su, Y., Wu, N., Yang, S., Shen, W., Sai, N., & Han, W.
- Venue
- Current Oncology
- Publisher
- MDPI AG
- Published
- 2025-11-12
- Volume
- 32
- Issue
- 11
- Pages
- 633
- ISSN
- 1718-7729
- Cited by
- 1
- References
- 3
- Language
- en
- Funders
- Beijing Natural Science Foundation (7242134, 7244412)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Von Hippel–Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype–Phenotype Features. https://app.cochat.ai/papers/10.3390/curroncol32110633
- The paper
- Wang, Q., Huang, J., Zhao, Z., Su, Y., Wu, N., Yang, S., Shen, W., Sai, N., & Han, W. (2025). Von Hippel–Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype–Phenotype Features. Current Oncology. https://doi.org/10.3390/curroncol32110633
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.